Exscientia (NASDAQ:EXAI – Free Report) had its target price trimmed by Morgan Stanley from $14.00 to $7.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Other analysts also recently issued research reports about the company. Berenberg Bank initiated coverage on […]
Exscientia plc (NASDAQ:EXAI – Get Free Report)’s stock price fell 2.6% during mid-day trading on Tuesday . The company traded as low as $4.45 and last traded at $4.45. 30,025 shares changed hands during trading, a decline of 93% from the average session volume of 416,585 shares. The stock had previously closed at $4.57. Analysts […]
Exscientia plc (NASDAQ:EXAI – Get Free Report) gapped down prior to trading on Wednesday after Bank of America lowered their price target on the stock from $16.00 to $11.00. The stock had previously closed at $4.59, but opened at $4.49. Exscientia shares last traded at $4.48, with a volume of 38,376 shares trading hands. Several […]
Shares of Exscientia plc (NASDAQ:EXAI – Get Free Report) shot up 3.5% during mid-day trading on Monday . The company traded as high as $5.32 and last traded at $5.32. 21,115 shares traded hands during trading, a decline of 94% from the average session volume of 339,252 shares. The stock had previously closed at $5.14. […]
Exscientia (NASDAQ:EXAI – Get Free Report) and Omega Therapeutics (NASDAQ:OMGA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current […]